Lv11
23 积分 2021-12-09 加入
Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS) enables accurate and user-friendly definitions of clinical remission and categories of disease activity
9小时前
已完结
Derivation and validation of the SLE Disease Activity Score (SLE-DAS): a new SLE continuous measure with high sensitivity for changes in disease activity
9小时前
已完结
Terminal Complement Inhibitor Ravulizumab in Generalized Myasthenia Gravis
13天前
已完结
Efficacy and Safety of Zabedosertib, an Interleukin-1 Receptor-Associated Kinase 4 Inhibitor, in Patients with Moderate-to-Severe Atopic Dermatitis: A Phase II Randomized Study
1个月前
已完结
Efficacy and Safety of Zimlovisertib, Ritlecitinib and Tofacitinib, Alone and in Combination, in Patients With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate
1个月前
已完结
中国中重度特应性皮炎诊疗临床路径专家共识（2023版）
1个月前
已完结
Expert consensus on the application and management of therapeutic drugs for atopic dermatitis （2024）
1个月前
已完结
Steroid Refractory Acute GVHD: The Hope for a Better Tomorrow
1个月前
已完结
Crovalimab treatment in patients with paroxysmal nocturnal haemoglobinuria: Long‐term results from the phase I/II COMPOSER trial
2个月前
已完结
Crovalimab treatment in patients with paroxysmal nocturnal haemoglobinuria: Long‐term results from the phase I/II COMPOSER trial
2个月前
已完结
皖公网安备34019202002308
